131 related articles for article (PubMed ID: 25164793)
1. High dose of prebiotics reduces fecal water cytotoxicity in healthy subjects.
Windey K; François I; Broekaert W; De Preter V; Delcour JA; Louat T; Herman J; Verbeke K
Mol Nutr Food Res; 2014 Nov; 58(11):2206-18. PubMed ID: 25164793
[TBL] [Abstract][Full Text] [Related]
2. Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children.
François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Hamer H; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):647-53. PubMed ID: 24368315
[TBL] [Abstract][Full Text] [Related]
3. Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects.
Windey K; De Preter V; Huys G; Broekaert WF; Delcour JA; Louat T; Herman J; Verbeke K
Br J Nutr; 2015 Jan; 113(2):225-38. PubMed ID: 25498469
[TBL] [Abstract][Full Text] [Related]
4. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial.
François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Evenepoel P; Hamer H; Houben E; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF
Br J Nutr; 2012 Dec; 108(12):2229-42. PubMed ID: 22370444
[TBL] [Abstract][Full Text] [Related]
5. Tolerance and the effect of high doses of wheat bran extract, containing arabinoxylan-oligosaccharides, and oligofructose on faecal output: a double-blind, randomised, placebo-controlled, cross-over trial.
François IE; Lescroart O; Veraverbeke WS; Windey K; Verbeke K; Broekaert WF
J Nutr Sci; 2014; 3():e49. PubMed ID: 26101617
[TBL] [Abstract][Full Text] [Related]
6. Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers.
Damen B; Cloetens L; Broekaert WF; François I; Lescroart O; Trogh I; Arnaut F; Welling GW; Wijffels J; Delcour JA; Verbeke K; Courtin CM
J Nutr; 2012 Mar; 142(3):470-7. PubMed ID: 22298569
[TBL] [Abstract][Full Text] [Related]
7. Modulation of protein fermentation does not affect fecal water toxicity: a randomized cross-over study in healthy subjects.
Windey K; De Preter V; Louat T; Schuit F; Herman J; Vansant G; Verbeke K
PLoS One; 2012; 7(12):e52387. PubMed ID: 23285019
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study.
Cloetens L; Broekaert WF; Delaedt Y; Ollevier F; Courtin CM; Delcour JA; Rutgeerts P; Verbeke K
Br J Nutr; 2010 Mar; 103(5):703-13. PubMed ID: 20003568
[TBL] [Abstract][Full Text] [Related]
9. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age.
Walton GE; van den Heuvel EG; Kosters MH; Rastall RA; Tuohy KM; Gibson GR
Br J Nutr; 2012 May; 107(10):1466-75. PubMed ID: 21910949
[TBL] [Abstract][Full Text] [Related]
10. Effects of abomasal oligofructose on blood and feces of Holstein steers.
Mainardi SR; Hengst BA; Nebzydoski SJ; Nemec LM; Gressley TF
J Anim Sci; 2011 Aug; 89(8):2510-7. PubMed ID: 21764841
[TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers.
Walton GE; Lu C; Trogh I; Arnaut F; Gibson GR
Nutr J; 2012 Jun; 11():36. PubMed ID: 22657950
[TBL] [Abstract][Full Text] [Related]
12. Fructooligosaccharides and Lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans.
Swanson KS; Grieshop CM; Flickinger EA; Bauer LL; Wolf BW; Chow J; Garleb KA; Williams JA; Fahey GC
J Nutr; 2002 Oct; 132(10):3042-50. PubMed ID: 12368393
[TBL] [Abstract][Full Text] [Related]
13. Oligofructose promotes satiety in healthy human: a pilot study.
Cani PD; Joly E; Horsmans Y; Delzenne NM
Eur J Clin Nutr; 2006 May; 60(5):567-72. PubMed ID: 16340949
[TBL] [Abstract][Full Text] [Related]
14. Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal.
Maki KC; Gibson GR; Dickmann RS; Kendall CW; Chen CY; Costabile A; Comelli EM; McKay DL; Almeida NG; Jenkins D; Zello GA; Blumberg JB
Nutrition; 2012; 28(11-12):1115-21. PubMed ID: 22771050
[TBL] [Abstract][Full Text] [Related]
15. A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects.
Sloan TJ; Jalanka J; Major GAD; Krishnasamy S; Pritchard S; Abdelrazig S; Korpela K; Singh G; Mulvenna C; Hoad CL; Marciani L; Barrett DA; Lomer MCE; de Vos WM; Gowland PA; Spiller RC
PLoS One; 2018; 13(7):e0201410. PubMed ID: 30048547
[TBL] [Abstract][Full Text] [Related]
16. Antigenotoxic activity of lactic acid bacteria, prebiotics, and products of their fermentation against selected mutagens.
Nowak A; Śliżewska K; Otlewska A
Regul Toxicol Pharmacol; 2015 Dec; 73(3):938-46. PubMed ID: 26404012
[TBL] [Abstract][Full Text] [Related]
17. The prebiotic, oligofructose-enriched inulin modulates the faecal metabolite profile: an in vitro analysis.
De Preter V; Falony G; Windey K; Hamer HM; De Vuyst L; Verbeke K
Mol Nutr Food Res; 2010 Dec; 54(12):1791-801. PubMed ID: 20568238
[TBL] [Abstract][Full Text] [Related]
18. Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects.
Costabile A; Fava F; Röytiö H; Forssten SD; Olli K; Klievink J; Rowland IR; Ouwehand AC; Rastall RA; Gibson GR; Walton GE
Br J Nutr; 2012 Aug; 108(3):471-81. PubMed ID: 22099384
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents--a placebo-controlled, diet-controlled trial.
Yen CH; Kuo YW; Tseng YH; Lee MC; Chen HL
Nutrition; 2011 Mar; 27(3):323-8. PubMed ID: 20579847
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Colonic Fermentation and Fecal Water Toxicity to the Pathophysiology of Lactose-Intolerance.
Windey K; Houben E; Deroover L; Verbeke K
Nutrients; 2015 Sep; 7(9):7505-22. PubMed ID: 26371036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
